The Indiana University School of Medicine conducts a broad range of basic, translational and clinical research in order to improve health, prevent disease, better train physicians and provide the foundation for Indiana's life sciences economy.  

The school holds more than $200 million in research grants and contracts, including more than $100 million in awards from the National Institutes of Health. It hosts federally designated centers of excellence in women’s health, cancer, kidney disease, Alzheimer disease and related disorders, alcohol research, arthritis, a general clinical research center, and sexually transmitted disease centers on both the pediatric and adult levels. Also affiliated with IU School of Medicine is the Regenstrief Institute, an international leader in medical informatics.

The school is home to $155 million Indiana Genomics Initiative, Indiana University’s multidisciplinary research enterprise that harnesses the power of genomics to promote health and prevent disease.

The IU School of Medicine is engaged in an aggressive program to double its research enterprise by adding nearly 400 new investigators, and to construct the state-of-the-art research facilities to accommodate them.